LOXL2 and breast cancer: We showed that LOXL2 plays a critical role in breast cancer progression, and further demonstrated that genetic, chemical, or antibody inhibition of LOXL2 significantly reduced the size and number of metastases in the lungs, liver, and bone through blocking the effects of extracellular LOXL2 on matrix remodeling and cell invasion [4].